NONSILICONE BREAST IMPLANT CLINICAL STUDY CONTROLS REQUIREMENTS
This article was originally published in The Gray Sheet
Executive Summary
NONSILICONE BREAST IMPLANT CLINICAL STUDY CONTROLS REQUIREMENTS remained unresolved among members of an FDA-convened panel of 17 scientific experts at an Oct. 21 workshop on alternatives to silicone gel-filled breast implants. The panel could not come to a consensus in response to FDA's question on establishing "appropriate control/comparison group for safety, effectiveness, and quality of life measures" for clinicals of breast implants filled with materials other than silicone gel.
You may also be interested in...
Lack Of Industry Involvement In Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.